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Identity 
Other names: ASFGF2, bFGF, FGF-2, FGF-AS, 
FGF2AS, gfg, gfg-1 
HGNC (Hugo): NUDT6 
Location: 4q28.1 




Human NUDT6 is located on chromosome 4 in the 
region of q28 on the reverse strand, opposite to FGF-2 
gene locus. FGF-2 and NUDT6 genes overlap at 3' 
ends, and the mRNAs form a sense-antisense pair. The 
NUDT6 mRNA (referred to as FGF-AS) has been 
implicated in the regulation of FGF2 mRNA stability. 
 
Figure A. The schematic representation of the overlap between human NUDT6 (FGF-AS) and FGF2 gene transcripts (colored boxes, 
coding region; connecting vertical lines, complementary regions between transcripts). Adapted from: MacFarlane LA, et al., 2010. 
Molecular Endocrinology 24. 
 






Atlas Genet Cytogenet Oncol Haematol. 2011; 15(1)  30 
 




The human NUDT6 gene is 34271 bp in length, 
composed of a 5'UTR, 16 exons, 6 introns and a 
3'UTR. The 5' and 3'UTR contain a variety of 
regulatory elements that regulate NUDT6 expression. 
NUDT6 gene transcription is regulated by a core 
promoter mapping from -1871 to +181 (relative to the 
transcription start site +1, up-stream -), which is 44 kb 
downstream from the FGF-2 promoter, however the 
proximal -151/+181 region confers almost full 
transcription activity. 
The promoter lacks a consensus TATA box or CCAAT 
element. The region between the first two exons 
contains two Sp1 transcription factor binding sites (-
372/-58 relative to the first exon start site). The 
common upstream region (all subsequent positions 
relative to first exon start site) from these start sites 
contains a multitude of tissue specific transcription 
factor binding sites, which include lymphocyte specific 
factors Ets at -229 and -83, GATA at -662 and +56, 
Lyf-1 at -981; skeletal muscle consensus E-boxes at -
901 and +30; cardiac factor Nkx-2.5 at -1501 and -582; 
liver and adipose C/EBP factor at -624; and testis 
specific factors SRY at -1740, -671, +163, +171 and 
Sox-5 at -1472, -632. 
Two negative regulatory elements also reside in this 
shared upstream region, at -1871 and -1315. The 
NUDT6 3'UTR contains a singe AU-rich element 
(ARE) and seven AU-rich-like sequences which 
negatively regulate mRNA stability. A portion of the 
NUDT6 coding region and 3'UTR (+531/+1167) is 
fully complementary to the 3'UTR of FGF2 and 
interaction through this region leads to the formation of 
a sense-antisense pair. 
Transcription 
The primary transcript can be alternatively spliced to 
produce at least 7 splice variants, a-d. Full length 
variants a and b only differ in the use of an alternative 
first exon, designated 1A or 1B. The 3' ends of the 
variants share sequence similarity. Two transcriptional 
start sites have been identified, one 15 bp upstream of 
the 1A exon (designated +1) and the other 84 bp 
upstream of the 1B exon (+312). It is unclear whether 
another transcription start site specific for other 
variants are located further downstream. 
NUDT6 transcripts are often designated FGF-AS (FGF 
antisense). The two longest transcripts, a and b, are 
classified as cis-antisense because they are transcribed 
from the same gene locus, on the opposite DNA strand 
and their 3'UTR is fully complementary to the 3'UTR 





Human NUDT6 encodes 3 novel nudix proteins with 
unknown function. 
Description 
NUDT6 splice variants a-c contain open reading frames 
(ORF) that predict isoforms of a novel nudix motif 
protein, originally designated GFG. The nudix box 
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Schematic representing predicted NUDT6 isoforms encoded by alternate splice RNA transcripts (deep blue boxes, nudix motif; light blue 
box, MTSP-mitochondrial targeting signal peptide). 
 
where X is any amino acid and U is a bulky 
hydrophobic amino acid, usually isoleucine, leucine or 
valine. To date, three different molecular weight 
isoforms have been identified in human, of 35, 28 and 
17 kDa, which are presumably generated by alternative 
translation initiation. Isoforms are designated as a, b or 
c however, this does not necessarily indicate that the 
isoform was synthesized from the corresponding 
transcript variant. The 35 kDa isoform is synthesized 
from the full length FGF-ASa, by translation initiation 
from the in-frame AUG codon located in exon 1A. The 
origin of the 28 kDa isoform is unclear. It is suspected 
that it is synthesized from an in-frame CUG codon in 
exon 2 of either FGF-AS a or b.  
However, it is possible that the 28 kDa product is a 
proteolytic fragment of the 35 kDa isoform. The 17 
kDa isoform may arise from translation initiation at an 
in-frame CUG codon in exon 3 of FGF-ASb or AUG 
codon in the first exon of FGF-ASc. The NUDT6 
isoforms are detected as stable homo- and hetero-
dimers by western blotting, which can be disrupted by 
dithiothreitol (DTT) and boiling. Potential dimerization 
domains have been mapped to both the N-terminus and 
COOH-terminus of NUDT6. 
Expression 
NUDT6 is expressed in a tissue and developmental 
stage specific manner. RNA transcripts are detected in 
most human tissues including liver, thymus, spleen, 
peripheral blood leukocytes, heart skeletal muscle, 
testis, colon and kidney. However, which transcript 
variants are expressed appears to be tissue specific. The 
full length FGF-ASb is thought to be the predominant 
variant in most tissues however variant FGF-ASa is the 
major variant in normal hematopoietic tissues. 
Furthermore, some tissues co-express FGF-2 and the 
ratio between FGF-2 and FGF-AS transcripts varies 
with tissue and development stage. FGF-AS levels are 
relatively low in many embryonic tissues, with 
expression increasing dramatically in a tissue specific 
manner postnatally. FGF-2 and FGF-AS exhibit an 
inverse relationship in normal tissues, tumor cell lines, 
embryonic development and throughout cell cycle 
progression. 
The level of NUDT6 expression and its ratio with FGF-
2 expression is frequently altered in tumors. Normal 
pituitary expresses moderate levels of NUDT6 and no 
FGF-2 while pituitary tumors have reduced NUDT6 
expression and high levels of FGF-2. The 
NUDT6/FGF-2 expression ratio decreases dramatically 
in tumors compared to normal tissue. Varying 
NUDT6/FGF-2 ratios have also been observed in 
esophageal adenocarcinomas. Additionally, transient 
increase in NUDT6 expression occurs in response to 
treatment with interleukin-2 and prolactin. 
Localisation 
NUDT6 can reside in the mitochondria, cytoplasm and 
nucleus, however its subcellular localization varies 
with isoform, cell type, disease state and extracellular 
stimulus. NUDT6a predominantly localizes to 
mitochondria whereas NUDT6b and NUDT6c 
primarily reside in the cytoplasm and nucleus. NUDT6 
is only found in the cytoplasm of normal esophageal 
squamous epithelial cells whereas in normal 
lymphocytes it is exclusively nuclear. However, 
transformation of these cells results in the redistribution 
of NUDT6. Cells from esophageal adenocarcinoma 
tumors and lymph nodes of patient with immunoblastic 
lymphoma localize NUDT6 to the nucleus and 
cytoplasm. 
Function 
The RNA and protein products appear to have distinct 
biological functions. NUDT6 mRNA (FGF-AS) plays a 
role in FGF-2 regulation, proliferation, and cell 
survival. Additionally, the NUDT6 protein has been 
implicated in the control of hormone production in the 
pituitary, and possibly in the removal of potentially 
hazardous compounds and metabolites by virtue of its 
conserved nudix domain. However, it is not always 
clear whether a specific action is a result of the RNA or 
protein function and this is further complicated by 
multiple antisense splice variants and protein isoforms. 
FGF-AS regulates FGF-2 transcript stability. Although 
the details of the mechanism involved are unclear, 
evidence suggest involvement of RNA interference 
and/or a dsRNA duplex formed between the 3'UTRs of 
FGF-AS and FGF-2. In addition to regulating FGF-2 
abundance it has been suggested that it also controls 
FGF-2 isoform translation and localization. The 
regulatory role of FGF-AS over FGF-2 is thought to 
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account for observed effects on cell proliferation and 
survival. 
NUDT6 protein is a nudix hydrolase which is a class of 
"house cleaning" enzymes capable of hydrolyzing a 
broad range of substrates, all defined as nucleoside 
diphosphates linked to some other moiety, that include 
nucleoside di- and triphosphates, dinucleoside and 
diphosphoinositol polyphosphates, nucleotide sugars 
and RNA caps. The substrate of human NUDT6 has yet 
to be elucidated and therefore its physiological function 
remains unknown. NUDT6 has observed effects on cell 
proliferation independent of those associated with FGF-
AS. NUDT6 overexpression in human colorectal 
cancer cells increases proliferation. Perhaps NUDT6's 
effects on proliferation are dependent on expression 
level, isoform and/or cell type, as is the case with FGF-
2. Furthermore, NUDT6 is involved in hormone 
production. GFG expression can increase levels of 
prolactin. However it is unclear if these effects are 
mediated through the same MAPK pathway utilized by 
FGF-2 to increase prolactin expression. 
Additionally, NUDT6 alters the isoform ratio of growth 
hormone, by increasing synthesis of the 22 kDa 
isoform and not the 20 kDa. 
Homology 
NUDT6 contains a conserved nudix motif common to 
other members of the Nudix family of 
phosphohydrolases. The Nudix motif is 
GXXXXXEXXXXXXXREUXEEXGU where U is 
Isoleucine, Leucine, or Valine and X is any amino acid. 
NUDT6 is highly conserved among man, cow, mouse, 
worm, and fruit fly, and GFG homologs across species 
are more evolutionarily related to each other than to 




Esophageal adenocarcinoma refers to uncontrolled 
growth of glandular cells in the esophagus and the 
junction between the esophagus and the stomach. 
Prognosis 
Elevated expression of FGF-AS in FGF-2 expressing 
esophageal adenocarcinomas is associated with reduced 
tumor reoccurrence following surgical resection of 
tumors and increased survival rates, suggesting that it 
may be used as a prognostic indicator. 
Oncogenesis 
Esophageal adendocarcinoma tumors overexpressed 
FGF-AS and cytoplasmic GFG in comparison to 
normal match esophageal tissue. However, the reduced 
tumor reoccurrence and improved survival rates 
specifically correlated to FGF-AS levels, not GFG 
levels. Evidence suggests FGF-AS tumor suppressive 




Melanoma is a malignant tumor of melanocytes, which 
are found primarily in the skin, however they can 
develop in melanocytes found in the eye and bowel. A 
characteristic of aggressive melanomas is their ability 
to form fluid-conducting vasculogenic-like networks. 
Oncogenesis 
A preliminary study investigating these 3D tubular 
networks within tumors identified NUDT6 as one of 
the many genes overexpressed in aggressive 
melanomas and speculated it is involved in promoting 
self-renewal and tumor cell plasticity in melanoma 
cancer networks. Additionally, they suggest FGF-AS 
could play a role in the development of the endothelia-
lined vasculature networks in melanomas indirectly 
through its regulatory control over FGF-2 expression, 




Colorectal cancer refers to uncontrolled growth of cells 
that line the colon, rectum and appendix, collectively 
the large intestine. 
Oncogenesis 
Induced overexpression of NUDT6 in a variety of 
human colorectal cells significantly increases cancer 
cell proliferation and their clonogenic capacity. 
NUDT6 is described as having tumor promoting 
functions in this cellular environment and it is 
suggested that it plays a role in colorectal cancer 
development and progression. 
Endometriosis 
Note 
Endometriosis is a medical condition affecting the 
endometrium lining of the uterus. The endometrium is 
comprised of hormonally responsive cells that 
proliferate and secrete under the influence of estrogen 
and progesterone. Upon menstruation the endometrium 
lining is shed as a part of the menstrual flow. 
Endometriosis describes the presence of endometrial 
cells outside of the uterus, such as the ovaries, fallopian 
tubes, bladder and interstitial space in the abdominal 
cavity. 
Patients with endometriosis lesions have reduced FGF-
AS-b mRNA levels and elevated FGF-2 mRNA levels 
during the late proliferative phase of the menstrual 
cycle, compared to control patients. This increased 
FGF/FGF-AS ratio is thought to contribute to the 
development of endometriosis. 
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